RALY and colorectal carcinoma: In CRC, it has been discovered that RALY, as an RNA-binding protein, can facilitate the post-transcriptional processing of specific miRNAs, such as miR-676, miR-483, and miR-877 with METTL3, thereby leading to increased ATP production and decreased ROS levels within CRC cells192.